SYRE
#1010
Spyre Therapeutics, Inc. - Common Stock
104.4 2 USD
+0.11%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+11.41%
Changement Mensuel
+28.01%
Evolution sur 6 mois
+213.95%
Changement Annuel
+336.72%
Clôture Précédente
93.7 3
Open
98.8 9
Low
98.6 7
High
104.7 3
Volume
1 233
Financials
- Market Capitalization 9.07 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-16.55
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 991 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.74 USD | +0.08% | +0.23% | +142.16% | +103.75% | 8.83 B USD | ||
| 1008 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.15 USD | +0.25% | -4.44% | +12.55% | +41.45% | 8.44 B USD | ||
| 1016 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 129.52 USD | -0.28% | -5.65% | +17.75% | +72.39% | 8.33 B USD | ||
| 1020 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.02 USD | +0.15% | +0.41% | +49.48% | +150.08% | 8.30 B USD |